D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement

计划入组 60 人 · 首次发布于 2014 年 7 月 30 日

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

计划入组 50 人 · 首次发布于 2018 年 10 月 24 日

Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)

计划入组 50 人 · 首次发布于 2018 年 10 月 22 日

Remoxipride

C₁₆H₂₃BrN₂O₃

Targeting D2 dopamine small molecule (ConfometRx)

Dopamine(Neoatricon)

C₈H₁₁NO₂ · Rx

Harmony Biosciences

United States

Cara Therapeutics

United States

Inventiva

IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression

Neumora Therapeutics Initiates Phase 1 Trial of Novel M4 Receptor Modulator NMRA-861 for Schizophrenia

FDA Approvals in 2024: NASH Treatment, DMD Therapy, Novel Schizophrenia Drug, and Breast Cancer Advancement